Literature DB >> 9180295

Cytokine response profiles of human myeloid factor-dependent leukemia cell lines.

H G Drexler1, M Zaborski, H Quentmeier.   

Abstract

Research in cytokine biology has grown exponentially in recent years as cytokines (often also termed growth factors) are now known to be involved in a wide range of pathological and physiological processes. Continuous human leukemia cell lines represent powerful tools to investigate these mechanisms. Most cell lines grow autonomously in standard culture media (containing fetal bovine serum) independent of externally added growth stimuli. Over the last 5-10 years a battery of myeloid leukemia-derived cell lines has been established that is constitutively dependent on the addition of cytokines to the culture. Such factor-dependent cell lines die rapidly by apoptosis when deprived of the appropriate growth factor. We determined the cytokine response profiles of 19 absolutely growth factor-dependent leukemia cell lines with myelomonocytic, erythroid or megakaryocytic phenotypes with regard to enhanced or suppressed cellular proliferation. Cells were incubated in liquid culture with optimal concentrations of various recombinant human cytokines known to have effects on the growth of hematopoietic cells. A proliferative or anti-proliferative response to these 41 cytokines was assessed by the short-term 3H-thymidine uptake assay. A proliferative response was considered as positive when the stimulation index (SI) was >2; inhibition was regarded as significant with an SI <0.5. The response profile of each cell line to these 41 cytokines was different and individual. None of the cell lines responded to one or two factors only (minimum to at least five cytokines). Proliferation of most (n = 13-17), but not of all cell lines was significantly enhanced by GM-CSF, IL-3, PIXY-321, SCF and IFN-gamma. TGF-beta1 consistently inhibited proliferation (in 11/19 cell lines). IFN-alpha, IFN-beta, TNF-alpha and TNF-beta had either stimulatory or inhibitory effects. The cell lines responding most often proliferatively (to 15-19 different cytokines) were UCSD/AML1, HU-3, TF-1 and M-07e. In summary, these factor-responsive human leukemia cell lines represent extremely useful model systems for the analysis of cytokine effects on hematopoietic cells. The cytokine response profiles of the individual cell lines provide guidelines for the selection of the appropriate cell culture for such experiments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180295     DOI: 10.1038/sj.leu.2400633

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells.

Authors:  I Plo; D Lautier; T Levade; H Sekouri; J P Jaffrézou; G Laurent; A Bettaïeb
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.

Authors:  X Jiang; A Lopez; T Holyoake; A Eaves; C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

3.  Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4Rα Antibody for Pulmonary Delivery.

Authors:  Harry W Pan; Han Cong Seow; Jason C K Lo; Jinlin Guo; Lingqiao Zhu; Susan W S Leung; Chenghai Zhang; Jenny K W Lam
Journal:  Pharm Res       Date:  2022-07-25       Impact factor: 4.580

4.  Human granulocyte-colony stimulating factor (G-CSF)/stem cell factor (SCF) fusion proteins: design, characterization and activity.

Authors:  Gitana Mickiene; Indrė Dalgėdienė; Gintautas Zvirblis; Zilvinas Dapkunas; Ieva Plikusiene; Ernesta Buzavaite-Verteliene; Zigmas Balevičius; Audronė Rukšėnaitė; Milda Pleckaityte
Journal:  PeerJ       Date:  2020-08-21       Impact factor: 2.984

5.  DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4).

Authors:  Hilmar Quentmeier; Sonja Eberth; Julia Romani; Herbert A Weich; Margarete Zaborski; Hans G Drexler
Journal:  BMC Cancer       Date:  2012-01-17       Impact factor: 4.430

6.  Cytokine Selection of MSC Clones with Different Functionality.

Authors:  Anton Selich; Teng-Cheong Ha; Michael Morgan; Christine S Falk; Constantin von Kaisenberg; Axel Schambach; Michael Rothe
Journal:  Stem Cell Reports       Date:  2019-07-11       Impact factor: 7.765

7.  Human leukocyte antigen class II quantification by targeted mass spectrometry in dendritic-like cell lines and monocyte-derived dendritic cells.

Authors:  A Casasola-LaMacchia; M S Ritorto; R J Seward; N Ahyi-Amendah; A Ciarla; T P Hickling; H Neubert
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

8.  Stem cell factor and NSC87877 combine to enhance c-Kit mediated proliferation of human megakaryoblastic cells.

Authors:  Pawan Kumar Raghav; Ajay Kumar Singh; Gurudutta Gangenahalli
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.